ERRα antagonist-1
CAS No. 1072145-33-5
ERRα antagonist-1 ( ERR+/- antagonist-1; ERRa antagonist-1 )
产品货号. M26207 CAS No. 1072145-33-5
ERRα antagonist-1 does not inhibit the interaction of either ERRβ or ERRγ with PGC-1α and PGC-1β coactivator, and also does not inhibit interaction of ERα or ERβ with PGC-1α or SRC-1.ERRα antagonist-1 is a selective and high affinity estrogen-related receptor α (ERRα) antagonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥551 | 有现货 |
|
10MG | ¥988 | 有现货 |
|
25MG | ¥2001 | 有现货 |
|
50MG | ¥3013 | 有现货 |
|
100MG | ¥4447 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称ERRα antagonist-1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述ERRα antagonist-1 does not inhibit the interaction of either ERRβ or ERRγ with PGC-1α and PGC-1β coactivator, and also does not inhibit interaction of ERα or ERβ with PGC-1α or SRC-1.ERRα antagonist-1 is a selective and high affinity estrogen-related receptor α (ERRα) antagonist.
-
产品描述ERRα antagonist-1 does not inhibit the interaction of either ERRβ or ERRγ with PGC-1α and PGC-1β coactivator, and also does not inhibit interaction of ERα or ERβ with PGC-1α or SRC-1.ERRα antagonist-1 is a selective and high affinity estrogen-related receptor α (ERRα) antagonist. ERRα antagonist-1 inhibits interaction of ERRα with Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and PGC-1β, the IC50 values are 170 nM and 180 nM, respectively.
-
同义词ERR+/- antagonist-1; ERRa antagonist-1
-
通路Endocrinology/Hormones
-
靶点Estrogen Receptor/ERR
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number1072145-33-5
-
分子量377.5
-
分子式C21H19N3S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC1CN=C(S1)N1CCS\C1=N/C1c2ccccc2C=Cc2ccccc12
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shi S, Liu Y, Wu J, Li Z, Zhao Y, Zhong D, Zeng F. Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers:an open-label, randomized-sequence, two-period crossover study. Clin Ther. 2010 Oct;32(11):1977-86.
产品手册
关联产品
-
Ulipristal acetate
Ulipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
-
Norethindrone
Norethindrone is a synthetic progestin, which mimic the actions of the endogenous ovarian hormone progesterone.
-
GDC-0927 racemate
GDC-0927 (SRN-927, RG-6047) is a potent, orally bioavailable, selective estrogen receptor degrader (SERD) for treatment of metastatic hormone receptor-positive/HER2-negative breast cancer.